Navigation Links
MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions

CHICAGO, June 21, 2007 /PRNewswire/ --

What and When

Data from the PROactive and CHICAGO studies of ACTOS(R) (pioglitazone HCl) will be presented in poster format at the 67th Scientific Sessions of the American Diabetes Association in Chicago:

    -- Hospitalizations for serious adverse events in high-risk type 2

       diabetes patients treated with pioglitazone for 3 years: results from

       PROactive; Poster 0553-P presented on Saturday, June 23, from 12:30-

       2:30 p.m. and 6:00-7:15 p.m.

    -- The relationship between renal dysfunction and major cardiovascular

       outcomes in patients with diabetes: experience from PROactive; Poster

       0670-P presented on Saturday, June 23, from 12:30-2:30 p.m. and 6:00-

       7:15 p.m.

    -- Effects of pioglitazone in patients with type 2 diabetes and reduced

       glomerular filtration rate: an analysis from PROactive; Poster 0671-P

       presented on Saturday, June 23, from 12:30-2:30 p.m. and 6:00-7:15 p.m.

    -- Effects of long-term treatment with pioglitazone on lipid levels in

       patients receiving statin therapy at baseline in the PROactive study;

       Poster 0905-P presented on Sunday, June 24, from 12-2 p.m. and 6:15-

       7:30 p.m.

    -- Comparative effects of pioglitazone and glimepiride on lipoprotein

       subfractions: results from the CHICAGO Trial; Poster 0906-P presented

       on Sunday, June 24, from 12-2 p.m. and 6:15-7:30 p.m.

    -- Long-term cost-effectiveness analysis on ACTOS for the USA from

       PROactive; Poster 1209-P presented on Sunday, June 24, from 12-2 p.m.

       and 6:15-7:30 p.m.

About ACTOS

ACTOS works by directly targeting insulin resistance, a condition in which the body does not efficiently use the insulin it produces to control blood glucose levels. ACTOS is taken once daily as an adjunct to diet and exercise, and is approved for use for t
'"/>




Page: 1 2 3

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
4. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
7. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
10. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation ... its Investigational New Drug Application (IND) to evaluate ... the U.S. Food and Drug Administration (FDA). OMS824 ... in areas of the brain linked to a ... Huntington,s disease and schizophrenia. OMS824 has shown promising ...
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
... N.D., Dec. 16, 2011  Crystal3 Labs, Inc., a cGMP contract ... today that it has been acquired by an individual ... of the transaction were not disclosed. The company also ... Founded in 2007, Global Pharma Analytics provides ...
... ( Medical Device and Diagnostic Industry , UBM ... latest news , information, and in-depth analysis, announced a series of ... of medical device design.  "We,re taking a close ... industry," stated Brian Buntz, Editor for MD+DI. "To some, the focus ...
Cached Medicine Technology:Crystal3 Labs Acquired by Individual Investor, Vithalbhai Dhaduk, M.D. 2MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation 2MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation 3
(Date:5/23/2013)... 2013 The sodium theory ... and B. Katz in the early 1950s, after their ... of sodium and potassium ions in nerve functions ... acquisition techniques have known amazing developments. In The Sodium ... give an account of the latest developments in the ...
(Date:5/23/2013)... 2013 Orange County film studio and visual ... light leaks for Apple's Final Cut Pro X ... you no longer have to worry about matching up the ... shot," Said Christina Austin, CEO of Pixel Film Studios, "You ... natural look." , ProLeak from Pixel Film Studios allows users ...
(Date:5/23/2013)... Dr. Damon Huffman of Huffman Family Dentistry is ... a revolutionary new treatment method with the Laser Assisted New ... suffer from periodontal disease, and many of them do not ... is hoping that LANAP will encourage many of those people ... , Periodontal disease can cause gums to recede and even ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Funeral Financials ... Memorial Day to the EOD Memorial Foundation ... be the greatest victims from the war. , ... originated in 1941 before the U.S. was even at ... Forces are identified with the Explosive Ordnance Disposal Badge. ...
(Date:5/23/2013)... Lake City, UT (PRWEB) May 23, 2013 ... 3.0 , a comprehensive radiology learning environment for ... with prebuilt lessons and assessments, transforms the learning ... comprehensive radiology curriculum. , “Until RADPrimer ... is second to none,” comments Dr. B.J. Manaster, ...
Breaking Medicine News(10 mins):Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2
... African swine fever, a devastating pig disease that could ... Organisation said Friday. ,"This is a dramatic ... the Rome-based FAO, noting that the highly contagious viral ... since 1990." ,Armenia, Azerbaidjan and Russia "should ...
... survivors can halve the risk of dying from the disease ... of their weight, suggests a longitudinal study from the ... (UCSD). ,Published in the Journal of Clinical Oncology, ... of a combination of both healthy diet and physical activity ...
... aging in fruit flies with a new technique that shows ... triumph for pests, scientists have found out how to make ... may still have something for humans. As reported online in ... slow down aging holds implications for humans prolonged existence and ...
... diagnosed cancer in men. More than 218,000 men will be ... 27,000 will die . June is Prostate Cancer Awareness Month, ... about the ways men can keep their prostates healthy and ... caused by benign prostatic enlargement affect the vast majority of ...
... department of Health today confirmed the death of a Madison County ... case in 2007 and it seems to be much earlier ... due to the virus. ,Four Mississippians have contracted West ... according to the Health Department and the Centers for Disease Control ...
... gave birth to twins at a hospital in London, where she ... ,The 47-year-old and her husband of ten years, Paul Berges, ... only next month. ,Predicting the early arrival of twins, ... and that she and Berges are really thrilled about it. ...
Cached Medicine News:Health News:Healthy Diet, Exercise can Halve the Risk of Mortality in Breast Cancer Survivors 2Health News:Super Fruit Fly may Harbor Hope for Human Longevity 2Health News:Tips to Maintain a Healthy Prostate 2Health News:First Case of West Nile Virus Death in Madison County 2
... nonsurgical, physician-administered treatment that can temporarily smooth ... brows in people from 18 to 65 ... treatment of its type approved by the ... Cosmetic is a purified protein produced by ...
... is a non-animal stabilized hyaluronic acid-based ... filler to enter the U.S. market. ... moderate to severe facial wrinkles and ... is injected just under the skins ...
... SCULPTRA™ is an injectable ... poly-L-lactic acid, a biocompatible, biodegradable, ... family. SCULPTRA is reconstituted prior ... of Sterile Water for Injection, ...
... is clinically proven to reduce the appearance ... cream-gel formula combines Retinol, the purest form ... Caffeine. It works deep within skin's surface ... bumpy appearance. Fast absorbing, it has a ...
Medicine Products: